A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer
Pavlenko, M, Roos, A-K, Lundqvist, A, Palmborg, A, Miller, A M, Ozenci, V, Bergman, B, Egevad, L, Hellström, M, Kiessling, R, Masucci, G, Wersäll, P, Nilsson, S, Pisa, PLanguage:
english
Pages:
1
Journal:
British Journal of Cancer
DOI:
10.1038/sj.bjc.6602019
Date:
July, 2004
File:
PDF, 135 KB
english, 2004